|
Volumn 3, Issue 1, 1998, Pages 26-33
|
New approaches to anticancer drug design based on the inhibition of farnesyltransferase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTINOPLANIC ACID B;
CHAETOMELLIC ACID A;
EPIDERMAL GROWTH FACTOR;
GUANINE NUCLEOTIDE BINDING PROTEIN;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
PROTEIN TYROSINE KINASE;
RAS PROTEIN;
SQUALENE SYNTHASE;
TRANSCRIPTION FACTOR;
UNCLASSIFIED DRUG;
ZARAGOZIC ACID A;
AMINO ACID SUBSTITUTION;
ANIMAL CELL;
ANIMAL MODEL;
CANCER INHIBITION;
CARCINOGENESIS;
COLON CANCER;
DRUG DESIGN;
DRUG EFFECT;
DRUG EFFICACY;
ENZYME CONFORMATION;
ENZYME INHIBITION;
GROWTH STIMULATION;
MALIGNANT TRANSFORMATION;
MOLECULAR MODEL;
MOUSE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
ONCOGENE RAS;
PANCREAS CANCER;
REVIEW;
SIGNAL TRANSDUCTION;
TRANSLATION REGULATION;
|
EID: 0031932939
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(97)01122-7 Document Type: Review |
Times cited : (44)
|
References (55)
|